These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20795899)

  • 21. Challenges in assessing nanomaterial toxicology: a personal perspective.
    Geraci CL; Castranova V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(6):569-77. PubMed ID: 20799267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of chemical composition and state of the surface on the toxic response to high aspect ratio nanomaterials.
    Fubini B; Fenoglio I; Tomatis M; Turci F
    Nanomedicine (Lond); 2011 Jul; 6(5):899-920. PubMed ID: 21793679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi wall carbon nanotubes induce oxidative stress and cytotoxicity in human embryonic kidney (HEK293) cells.
    Reddy AR; Reddy YN; Krishna DR; Himabindu V
    Toxicology; 2010 Jun; 272(1-3):11-6. PubMed ID: 20371264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants.
    Pulskamp K; Diabaté S; Krug HF
    Toxicol Lett; 2007 Jan; 168(1):58-74. PubMed ID: 17141434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment?
    Moore MN
    Environ Int; 2006 Dec; 32(8):967-76. PubMed ID: 16859745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological properties of engineered nanomaterials.
    Dobrovolskaia MA; McNeil SE
    Nat Nanotechnol; 2007 Aug; 2(8):469-78. PubMed ID: 18654343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health--lessons learned from four case studies.
    Aschberger K; Micheletti C; Sokull-Klüttgen B; Christensen FM
    Environ Int; 2011 Aug; 37(6):1143-56. PubMed ID: 21397332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nanotubes and occupational medicine].
    Borrelli I
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):851-2. PubMed ID: 18409997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Toxicology of Engineered Nanomaterials in Asthma.
    Ihrie MD; Bonner JC
    Curr Environ Health Rep; 2018 Mar; 5(1):100-109. PubMed ID: 29441464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nanoparticle dispersion method for in vitro and in vivo nanotoxicity study.
    Kim SC; Chen DR; Qi C; Gelein RM; Finkelstein JN; Elder A; Bentley K; Oberdörster G; Pui DY
    Nanotoxicology; 2010 Mar; 4(1):42-51. PubMed ID: 20795901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic effects of aggregated nanomaterials.
    Soto K; Garza KM; Murr LE
    Acta Biomater; 2007 May; 3(3):351-8. PubMed ID: 17275430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health effects of inhaled engineered and incidental nanoparticles.
    Madl AK; Pinkerton KE
    Crit Rev Toxicol; 2009; 39(8):629-58. PubMed ID: 19743943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk management strategy to increase the safety of workers in the nanomaterials industry.
    Ling MP; Lin WC; Liu CC; Huang YS; Chueh MJ; Shih TS
    J Hazard Mater; 2012 Aug; 229-230():83-93. PubMed ID: 22727485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of nanotoxicology in realizing the 'helping without harm' paradigm of nanomedicine: lessons from studies of pulmonary effects of single-walled carbon nanotubes.
    Shvedova AA; Kagan VE
    J Intern Med; 2010 Jan; 267(1):106-18. PubMed ID: 20059647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manufactured nanoparticles: an overview of their chemistry, interactions and potential environmental implications.
    Ju-Nam Y; Lead JR
    Sci Total Environ; 2008 Aug; 400(1-3):396-414. PubMed ID: 18715626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials.
    Thomas K; Sayre P
    Toxicol Sci; 2005 Oct; 87(2):316-21. PubMed ID: 16049265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pitfalls of a systematic MEDLINE review in palliative medicine: symptom assessment instruments.
    O'Leary N; Tiernan E; Walsh D; Lucey N; Kirkova J; Davis MP
    Am J Hosp Palliat Care; 2007; 24(3):181-4. PubMed ID: 17601840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique.
    Murdock RC; Braydich-Stolle L; Schrand AM; Schlager JJ; Hussain SM
    Toxicol Sci; 2008 Feb; 101(2):239-53. PubMed ID: 17872897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicity evaluations of various carbon nanomaterials.
    Uo M; Akasaka T; Watari F; Sato Y; Tohji K
    Dent Mater J; 2011; 30(3):245-63. PubMed ID: 21597228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.